@Bhakti_Purple @StevenPulido @NIH That's the kicker, even back then it was painfully obvious. That's why they lied. Feb 27, 2020: "Lymphopenia (75.4%) and eosinopenia (52.9%) were observed in most patients." Your immune system doesn't regenerate, once it
RT @FlorinDanPopesc: @EAACI_HQ @AllergyEaaci @siaf #News: #asthma or #allergy not a risk factor for the SARS-CoV-2 infection [Jin-jin Zhang…
RT @AllergyEaaci: It is a great pleasure to recognize one of the first clinical COVID-19 papers published online in Allergy on the 19th of…
It is a great pleasure to recognize one of the first clinical COVID-19 papers published online in Allergy on the 19th of February 2020, before the first cases were reported in Europe (https://t.co/yOXTjlbzup). https://t.co/1VzYIY3Ju4
Du H, Dong X, Zhang JJ, Cao YY, Akdis M, Huang PQ, Chen HW, Li Y, Liu GH, Akdis CA, Lu XX, Gao YD. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021;76:510-532. 👇https://t.co/n73ZqcClnJ
@lynnmck39369269 @tweets4tom @mikepfingston2 From 2/20 “The relationship between smoking and coronavirus infection is not clear, and the exact underlying causes of the lower incidence of COVID-19 in current smokers are still unknown” https://t.co/CCLlr7t
@avgustdez Вот этот отчет: https://t.co/1ZA0mk1HXX
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
RT @AllergyEaaci: One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9)…
One year on: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China (https://t.co/50QEkNJ8L9) One year from today, Allergy published the first paper on COVID-19 in the context of allergy. 960 citations, an indication of the im
Free Access: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. First author: Jin-jin Zhang. First Published: 19 February 2020. Download Article Here: https://t.co/TkvjJ6zmxi
Free Access: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. First author: Jin-jin Zhang; corresponding author:Ya-dong Gao. First Published: 19 February 2020. Download Article Here: https://t.co/TkvjJ6zmxi
1,675/ China (adult smoking rate was 26.6% in 2018) CS=current smoking; PS=past smoking Of 140 hospitalized, CS=2 (1.4%) & PS=7 (5%) Of 58 with severe cases, CS=2 (3.4%) & PS=4 (6.9%) https://t.co/VTN3VoKpnK
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [Feb 19, 2020] Zhang et al. Allergy https://t.co/P9CCFEyNii #2019nCoV n=140 hospitalized #COVID19 cases. Eosinopenia + lymphopenia Dx indicators https://t.co/exhoTAbPPV
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [Feb 19, 2020] Zhang et al. Allergy https://t.co/P9CCFEyNii #2019nCoV n=140 hospitalized #COVID19 cases. Eosinopenia + lymphopenia Dx indicators https://t.co/3h45EYaZjq
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [Feb 19, 2020] Zhang et al. Allergy https://t.co/P9CCFEyNii #2019nCoV n=140 hospitalized #COVID19 cases. Eosinopenia + lymphopenia Dx indicators https://t.co/KOZKRzkorF
RT @AllergyEaaci: Top liked in social media.
RT @AllergyEaaci: Top liked in social media.
RT @AllergyEaaci: Top liked in social media.
RT @AllergyEaaci: Top liked in social media.
RT @AllergyEaaci: Top liked in social media.
RT @AllergyEaaci: Top liked in social media. https://t.co/guctueuyEN
Top liked in social media.
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
The iceberg of #COVID19 is a brilliant piece of work!
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
RT @AllergyEaaci: Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 i…
Check out Allergy´s COVID-19 articles. (Free Access) Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China https://t.co/TkvjJ6zmxi Eleven faces of coronavirus disease 2019. https://t.co/QAqURShQ5W https://t.co/aVLbuRjyY2
RT @alextaylormd: #CoVID19 presents with lymphopenia and eosinopenia rather than lymphocytosis https://t.co/09Fd1xnBEy
https://t.co/QiMb1xHA4k Ну вот теперь я спокоен :) https://t.co/It5HwyKxF5
@VirusEmpathy I know, dear. Har tweetet om emnet i månedsvis ... 😊 https://t.co/9YgtnrZLjr
RT @DarioAntolin: La #alergia parece no ser factor de riesgo para #COVID19 #AllergyRev20 https://t.co/NmFdwKcClx
RT @DarioAntolin: La #alergia parece no ser factor de riesgo para #COVID19 #AllergyRev20 https://t.co/NmFdwKcClx
La #alergia parece no ser factor de riesgo para #COVID19 #AllergyRev20 https://t.co/NmFdwKcClx
Alın bu da ispatı...ekteki raporları inceleyin.. Ayrıca Wuhan'daki araştırmada da benzer sonuç var.. 1085 hastanın 927'si hiç sigara içmemiş... ACE2 reseptörünü nikotin baskılıyor... Hücre içine virüsün girmesini önlüyormuş.. CDC Abd araştırmasında ise ora
@ProfDemirtas Çinde yapılan bir çalışmada astımın risk faktörlerinden olmadığı gösterilmiş. (Bu çalışma kısıtlı sayıda hasta ile yapılmıştı.. ) https://t.co/ysPJASDkrO
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
@wPolityce_pl Chińczycy, ale nie w marcu a w lutym. Sam czytałem o tym już w lutym. Tu jest ten raport. https://t.co/dc5sgh76dR https://t.co/EYKUDbppC8
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
RT @EAACI_HQ: In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initi…
In #COVID19 patients, #lymphopenia is common & more than half have #eosinopenia, without significant difference between initial (+) and (-) RT-PCR results for SARS-CoV-2 #EAACImonthly #Allergy_journal 🔗Zhang JJ, et al. https://t.co/AikOXgoYZd &
@TelukTomasz O tym pierwszy raz przeczytałem już w lutym. https://t.co/dc5sgh76dR
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
RT @waznyandrzej3: @a_hrechorowicz To nie nowość. Takie wnioski wysuwano już w lutym. https://t.co/dc5sgh76dR
@Prusis Nezinu, kas ir tie visi. Vīruss izplatās saulainās un karstās valstīs tik pat ātri, ka visas pārējās. Lai spriestu ir nepieciešamas lasīt pašu zinātnieku pētījumu. Piemēram, viens no pētījumiem atrada anomāliju, ka slimība mazāk skar smēķētājus. ht
@a_hrechorowicz To nie nowość. Takie wnioski wysuwano już w lutym. https://t.co/dc5sgh76dR
個人的メモ: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. - PubMed - NCBI https://t.co/vdFxzyFdAB
@AnninFrance1 @DavidPForsyth @plopnl @plantmann_1 @N_Zillatron @ChaunceyGardner @TrevorSutcliffe @wokelikekyrie @mihotep @jkelovuori @michelleminton @JSheltzer @mattmight @eperlste @cispt2 The studies are showing that very few smokers have been hospitalize
@Forest_Smoking Somehow I knew something strange was going on when I saw the first 3 Chinese studies in the first week of March: https://t.co/9YgtnrZLjr
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
inanmak istiyorum 🙏 inamasam ne değişecek 😂😂 yine içeceğim 🤓 ama iyi detay bulmuş abi ! birçok insan için bir çok sorunun cevabı aynı zamanda https://t.co/xZBNUWMZbo
@Pefirsb Me compartieron esto por si te interesa: https://t.co/mkIGh8Fdc8
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
RT @FlorinDanPopesc: @OMatsuno2 Yes ! #Asthma is not risk factors for SARS-CoV-2 infection [Zhang JJ, Dong X, Cao YY, et al. Allergy. 2020]…
RT @FlorinDanPopesc: @OMatsuno2 Yes ! #Asthma is not risk factors for SARS-CoV-2 infection [Zhang JJ, Dong X, Cao YY, et al. Allergy. 2020]…
@LucreSnooker @toad_spotted It's likely real. https://t.co/AXzqii7aRC
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
Za pušače. https://t.co/PiyQEXqBwd
@OMatsuno2 Yes ! #Asthma is not risk factors for SARS-CoV-2 infection [Zhang JJ, Dong X, Cao YY, et al. Allergy. 2020] and fortunately the available data reveal that almost all of the patients with asthma are not severely affected [WAO, 2020] https://t.co/
Det her er en af de vildeste profiler, jeg er stødt på på Twitter. Klaus, manden bag bl.a. ‘Sig du ka li mig’ og ‘er der nogen i himlen’ har dedikeret sin profil til at fremme rygning som et middel mod covid-19. Like og del-amok fra kæmpe bot-hær. #corona
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…
RT @EAACI_HQ: #Urticaria may be detected in patients with #COVID19 & #coronavirus pneumonia was reported in chronic spontaneous urticaria!…
RT @KlausKblog: Does smoking & vaping protect against coronavirus? Very likely. Three studies of confirmed cases showed that ~90 pct of pat…